COCH
Envoy Medical, Inc.
Price Chart
Latest Quote
$0.63
-0.02 (-3.12%)
Current Price
| Previous Close | $0.65 |
| Open | $0.65 |
| Day High | $0.68 |
| Day Low | $0.63 |
| Volume | 358,485 |
Stock Information
| Shares Outstanding | 77.02M |
| Total Debt | $889K |
| Cash Equivalents | $25.25M |
| Revenue | $234K |
| Net Income | $-28.13M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $48.83M |
| EPS (TTM) | $-1.02 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $25.49M |
| Sales | $234K |
| Income | $-28.13M |
| Book/sh | $0.14 |
| Cash/sh | $0.33 |
| Employees | 43 |
Financial Ratios
| Quick Ratio | 2.07 |
| Current Ratio | 2.27 |
| Debt/Eq | 8.43 |
Returns & Margins
| ROA | -71.29% |
| Gross Margin | -229.49% |
| Operating Margin | -15279.49% |
Ownership
| Insider Ownership | 38.59% |
| Institutional Ownership | 22.89% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.11 |
| P/S | 208.68 |
| P/B | 4.63 |
Analyst Data
| Recommendation | none |
| Target Price | $2.50 |
Technical Indicators
| SMA20 | $0.67 |
| SMA50 | $0.68 |
| SMA200 | $0.76 |
| RSI | 34.62 |
| ATR | 0.0380 |
| Shares Float | 38.09M |
| Short Float | 2.52% |
| Short Ratio | 9.67 |
| Volatility | 1.89 |
| Rel Volume | 3.05 |
Performance History
| Week | -3.65% |
| Month | -14.32% |
| Quarter | -23.34% |
| 6 Months | -12.19% |
| YTD | -8.91% |
| Year | -54.71% |
| 3 Years | -93.79% |
| 5 Years | -93.46% |
| 10 Years | -93.50% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.63 | 389,700 |
| 2026-06-17 | $0.65 | 43,900 |
| 2026-06-16 | $0.65 | 52,600 |
| 2026-06-15 | $0.64 | 65,900 |
| 2026-06-12 | $0.63 | 57,300 |
| 2026-06-11 | $0.66 | 95,900 |
| 2026-06-10 | $0.65 | 97,800 |
| 2026-06-09 | $0.62 | 188,600 |
| 2026-06-08 | $0.66 | 102,500 |
| 2026-06-05 | $0.66 | 97,000 |
| 2026-06-04 | $0.70 | 197,800 |
| 2026-06-03 | $0.69 | 46,900 |
| 2026-06-02 | $0.70 | 365,800 |
| 2026-06-01 | $0.70 | 140,700 |
| 2026-05-29 | $0.71 | 47,400 |
| 2026-05-28 | $0.70 | 73,400 |
| 2026-05-27 | $0.69 | 85,600 |
| 2026-05-26 | $0.70 | 155,200 |
| 2026-05-22 | $0.71 | 72,500 |
| 2026-05-21 | $0.73 | 178,000 |
| 2026-05-20 | $0.73 | 120,400 |
| 2026-05-19 | $0.74 | 210,800 |
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
đ° Latest News
TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates
Zacks âĸ 2026-05-05T22:05:19Z
Positive Signs As Multiple Insiders Buy Envoy Medical Stock
Simply Wall St. âĸ 2025-12-09T12:52:28Z
Envoy Medical, Inc. (COCH) Upgraded to Buy: Here's Why
Zacks âĸ 2025-12-03T17:00:03Z
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2025-11-10T14:40:02Z
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
Zacks âĸ 2025-11-06T23:15:03Z
Envoy Medical, Inc. (COCH) Expected to Beat Earnings Estimates: Should You Buy?
Zacks âĸ 2025-11-06T15:00:05Z
Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates
Zacks âĸ 2025-11-04T14:15:01Z
OrthoPediatrics (KIDS) Reports Q3 Loss, Misses Revenue Estimates
Zacks âĸ 2025-10-28T21:15:03Z
Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' Now
Zacks âĸ 2025-10-20T13:55:01Z
Top Midday Decliners
MT Newswires âĸ 2025-10-08T18:18:21Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $874,000 | $742,000 | $789,000 | $498,000 |
| Cost Of Revenue | $874,000 | $742,000 | $789,000 | $498,000 |
| Total Revenue | $241,000 | $225,000 | $316,000 | $237,000 |
| Operating Revenue | $241,000 | $225,000 | $316,000 | $237,000 |
| Expenses | ||||
| Interest Expense | $1,590,000 | $816,000 | $0 | - |
| Total Expenses | $22,511,000 | $19,481,000 | $18,675,000 | $8,943,000 |
| Other Income Expense | $104,000 | $-723,000 | $-11,563,000 | $-7,217,000 |
| Other Non Operating Income Expenses | $-23,000 | $-26,000 | $-13,278,000 | $-7,217,000 |
| Net Non Operating Interest Income Expense | $-1,590,000 | $-816,000 | $0 | - |
| Interest Expense Non Operating | $1,590,000 | $816,000 | $0 | - |
| Operating Expense | $21,637,000 | $18,739,000 | $17,886,000 | $8,445,000 |
| Selling And Marketing Expense | $1,220,000 | $1,734,000 | $1,666,000 | $885,000 |
| General And Administrative Expense | $7,931,000 | $6,826,000 | $7,264,000 | $2,585,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Net Interest Income | $-1,590,000 | $-816,000 | $0 | - |
| Normalized Income | $-23,883,000 | $-20,098,000 | $-31,637,000 | $-15,923,000 |
| Net Income From Continuing And Discontinued Operation | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Total Operating Income As Reported | $-22,270,000 | $-19,256,000 | $-18,359,000 | $-8,706,000 |
| Net Income Common Stockholders | $-28,662,000 | $-27,973,000 | $-31,271,000 | $-15,923,000 |
| Net Income | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Net Income Including Noncontrolling Interests | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Net Income Continuous Operations | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Pretax Income | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Operating Income | $-22,270,000 | $-19,256,000 | $-18,359,000 | $-8,706,000 |
| Gross Profit | $-633,000 | $-517,000 | $-473,000 | $-261,000 |
| Per Share | ||||
| Diluted EPS | $-1.23 | $-1.49 | $-2.54 | $-1.57 |
| Basic EPS | $-1.23 | $-1.49 | $-2.54 | $-1.57 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-21,991,000 | $-19,109,000 | $-31,504,000 | $-8,631,000 |
| Total Unusual Items | $127,000 | $-697,000 | $1,715,000 | - |
| Total Unusual Items Excluding Goodwill | $127,000 | $-697,000 | $1,715,000 | - |
| Reconciled Depreciation | $302,000 | $173,000 | $133,000 | $75,000 |
| EBITDA (Bullshit earnings) | $-21,864,000 | $-19,806,000 | $-29,789,000 | $-8,631,000 |
| EBIT | $-22,166,000 | $-19,979,000 | $-29,922,000 | $-8,706,000 |
| Diluted Average Shares | $23,259,598 | $18,790,448 | $12,295,391 | $10,153,564 |
| Basic Average Shares | $23,259,598 | $18,790,448 | $12,295,391 | $10,153,564 |
| Diluted NI Availto Com Stockholders | $-28,662,000 | $-27,973,000 | $-31,271,000 | $-15,923,000 |
| Otherunder Preferred Stock Dividend | $0 | $1,657,000 | $0 | - |
| Preferred Stock Dividends | $4,906,000 | $5,521,000 | $1,349,000 | $2,000,000 |
| Gain On Sale Of Security | $127,000 | $-697,000 | $1,715,000 | - |
| Research And Development | $12,486,000 | $10,179,000 | $8,956,000 | $4,975,000 |
| Selling General And Administration | $9,151,000 | $8,560,000 | $8,930,000 | $3,470,000 |
| Other Gand A | $7,931,000 | $6,826,000 | $7,264,000 | $2,585,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-11,767,000 | $-18,842,000 | $-1,776,000 | $-36,195,000 |
| Total Assets | $8,558,000 | $11,538,000 | $8,271,000 | $2,556,000 |
| Total Non Current Assets | $2,279,000 | $2,642,000 | $815,000 | $908,000 |
| Non Current Prepaid Assets | $358,000 | $488,000 | - | - |
| Current Assets | $6,279,000 | $8,896,000 | $7,456,000 | $1,648,000 |
| Other Current Assets | $941,000 | $887,000 | $1,588,000 | $129,000 |
| Inventory | $1,546,000 | $1,708,000 | $1,404,000 | $1,295,000 |
| Receivables | $53,000 | $818,000 | $246,000 | $41,000 |
| Other Receivables | $19,000 | $780,000 | $176,000 | - |
| Accounts Receivable | $34,000 | $38,000 | $70,000 | $41,000 |
| Cash Cash Equivalents And Short Term Investments | $3,739,000 | $5,483,000 | $4,218,000 | $183,000 |
| Cash And Cash Equivalents | $3,739,000 | $5,483,000 | $4,218,000 | $183,000 |
| Cash Financial | $3,739,000 | $5,483,000 | $4,218,000 | $183,000 |
| Prepaid Assets | - | - | - | $129,000 |
| Debt | ||||
| Total Debt | $919,000 | $19,661,000 | $562,000 | $34,535,000 |
| Long Term Debt And Capital Lease Obligation | $745,000 | $19,518,000 | $404,000 | $33,962,000 |
| Current Debt And Capital Lease Obligation | $174,000 | $143,000 | $158,000 | $573,000 |
| Net Debt | - | $13,233,000 | - | $33,662,000 |
| Long Term Debt | - | $18,716,000 | - | $33,397,000 |
| Current Debt | - | - | - | $448,000 |
| Other Current Borrowings | - | - | - | $448,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $20,325,000 | $30,380,000 | $10,047,000 | $38,751,000 |
| Total Non Current Liabilities Net Minority Interest | $8,763,000 | $22,842,000 | $2,762,000 | $36,232,000 |
| Other Non Current Liabilities | $27,000 | $891,000 | - | - |
| Derivative Product Liabilities | $7,991,000 | $2,433,000 | $2,358,000 | $2,270,000 |
| Current Liabilities | $11,562,000 | $7,538,000 | $7,285,000 | $2,519,000 |
| Other Current Liabilities | $829,000 | $1,327,000 | $960,000 | $335,000 |
| Payables And Accrued Expenses | $10,559,000 | $6,068,000 | $6,167,000 | $1,611,000 |
| Interest Payable | $0 | $703,000 | - | - |
| Payables | $8,626,000 | $1,652,000 | $1,554,000 | $1,003,000 |
| Dividends Payable | $3,778,000 | - | - | - |
| Total Tax Payable | $1,928,000 | - | - | $6,000 |
| Accounts Payable | $2,920,000 | $1,652,000 | $1,554,000 | $1,003,000 |
| Current Deferred Liabilities | - | - | - | $15,000 |
| Equity | ||||
| Common Stock Equity | $-11,767,000 | $-18,842,000 | $-1,776,000 | $-36,195,000 |
| Total Equity Gross Minority Interest | $-11,767,000 | $-18,842,000 | $-1,776,000 | $-36,195,000 |
| Stockholders Equity | $-11,767,000 | $-18,842,000 | $-1,776,000 | $-36,195,000 |
| Other Equity Interest | $391,000 | - | - | - |
| Gains Losses Not Affecting Retained Earnings | $-120,000 | $-123,000 | $-118,000 | $-115,000 |
| Other Equity Adjustments | $-120,000 | $-123,000 | $-118,000 | $-115,000 |
| Retained Earnings | $-313,396,000 | $-284,734,000 | $-257,256,000 | $-225,985,000 |
| Preferred Securities Outside Stock Equity | - | - | - | $19,973,000 |
| Other | ||||
| Ordinary Shares Number | $28,934,960 | $21,326,609 | $19,599,982 | $19,549,982 |
| Share Issued | $28,934,960 | $21,326,609 | $19,599,982 | $19,549,982 |
| Tangible Book Value | $-11,767,000 | $-18,842,000 | $-1,776,000 | $-36,195,000 |
| Invested Capital | $-11,767,000 | $-126,000 | $-1,776,000 | $-2,350,000 |
| Working Capital | $-5,283,000 | $1,358,000 | $171,000 | $-871,000 |
| Capital Lease Obligations | $919,000 | $945,000 | $562,000 | $690,000 |
| Total Capitalization | $-11,767,000 | $-126,000 | $-1,776,000 | $-2,798,000 |
| Additional Paid In Capital | $301,355,000 | $266,013,000 | $255,596,000 | $189,904,000 |
| Capital Stock | $3,000 | $2,000 | $2,000 | $1,000 |
| Common Stock | $3,000 | $2,000 | $2,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $745,000 | $802,000 | $404,000 | $565,000 |
| Current Capital Lease Obligation | $174,000 | $143,000 | $158,000 | $125,000 |
| Current Accrued Expenses | $1,933,000 | $4,416,000 | $4,613,000 | $608,000 |
| Net PPE | $1,921,000 | $2,154,000 | $815,000 | $908,000 |
| Accumulated Depreciation | $-5,109,000 | $-4,830,000 | $-4,657,000 | $-4,529,000 |
| Gross PPE | $7,030,000 | $6,984,000 | $5,472,000 | $908,000 |
| Other Properties | $5,389,000 | $5,355,000 | $4,258,000 | $908,000 |
| Machinery Furniture Equipment | $755,000 | $750,000 | $750,000 | $754,000 |
| Buildings And Improvements | $886,000 | $879,000 | $464,000 | - |
| Properties | $0 | $0 | $0 | - |
| Finished Goods | $196,000 | $119,000 | $84,000 | $121,000 |
| Work In Process | $88,000 | $203,000 | $158,000 | $164,000 |
| Raw Materials | $1,262,000 | $1,386,000 | $1,162,000 | $1,010,000 |
| Current Deferred Revenue | - | - | - | $15,000 |
| Construction In Progress | - | - | - | $4,106,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-18,380,000 | $-18,929,000 | $-17,244,000 | $-9,023,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-18,201,000 | $-17,949,000 | $-17,091,000 | $-8,805,000 |
| Cash Flow From Continuing Operating Activities | $-18,201,000 | $-17,949,000 | $-17,091,000 | $-8,805,000 |
| Operating Gains Losses | $-127,000 | $697,000 | $-1,842,000 | $35,000 |
| Investing Activities | ||||
| Capital Expenditure | $-179,000 | $-980,000 | $-153,000 | $-218,000 |
| Investing Cash Flow | $-179,000 | $-980,000 | $-153,000 | $-218,000 |
| Cash Flow From Continuing Investing Activities | $-179,000 | $-980,000 | $-153,000 | $-218,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,098,000 | $1,746,000 | $11,845,000 | $0 |
| Financing Cash Flow | $16,633,000 | $20,198,000 | $21,282,000 | $8,092,000 |
| Cash Flow From Continuing Financing Activities | $16,633,000 | $20,198,000 | $21,282,000 | $8,092,000 |
| Net Other Financing Charges | $-930,000 | $-916,000 | $-563,000 | - |
| Cash Dividends Paid | $-1,819,000 | $-2,447,000 | $0 | - |
| Preferred Stock Dividend Paid | $-1,819,000 | $-2,447,000 | $0 | - |
| Net Common Stock Issuance | $7,098,000 | $1,746,000 | $109,000 | $0 |
| Common Stock Issuance | $7,098,000 | $1,746,000 | $109,000 | $0 |
| Net Preferred Stock Issuance | - | $0 | $11,736,000 | $0 |
| Preferred Stock Issuance | - | $0 | $11,736,000 | $0 |
| Other | ||||
| Repayment Of Debt | $-827,000 | $-916,000 | $-563,000 | - |
| Issuance Of Debt | $10,000,000 | $20,000,000 | $10,000,000 | $8,000,000 |
| Interest Paid Supplemental Data | $36,000 | $41,000 | $26,000 | $0 |
| End Cash Position | $3,739,000 | $5,483,000 | $4,218,000 | $183,000 |
| Beginning Cash Position | $5,483,000 | $4,219,000 | $183,000 | $1,121,000 |
| Effect Of Exchange Rate Changes | $3,000 | $-5,000 | $-3,000 | $-7,000 |
| Changes In Cash | $-1,747,000 | $1,269,000 | $4,038,000 | $-931,000 |
| Proceeds From Stock Option Exercised | $3,111,000 | $1,815,000 | $0 | $92,000 |
| Net Issuance Payments Of Debt | $9,173,000 | $19,084,000 | $9,437,000 | $8,000,000 |
| Net Long Term Debt Issuance | $9,173,000 | $19,084,000 | $9,437,000 | $8,000,000 |
| Long Term Debt Payments | $-827,000 | $-916,000 | $-563,000 | - |
| Long Term Debt Issuance | $10,000,000 | $20,000,000 | $10,000,000 | $8,000,000 |
| Net PPE Purchase And Sale | $-179,000 | $-980,000 | $-153,000 | $-218,000 |
| Purchase Of PPE | $-179,000 | $-980,000 | $-153,000 | $-218,000 |
| Change In Working Capital | $1,839,000 | $-638,000 | $-983,000 | $-160,000 |
| Change In Other Current Liabilities | $-1,268,000 | $565,000 | $-372,000 | $-526,000 |
| Change In Payables And Accrued Expense | $2,224,000 | $-260,000 | $457,000 | $475,000 |
| Change In Accrued Expense | $839,000 | $-241,000 | $-94,000 | $133,000 |
| Change In Payable | $1,385,000 | $-19,000 | $551,000 | $342,000 |
| Change In Account Payable | $1,385,000 | $-19,000 | $551,000 | $342,000 |
| Change In Prepaid Assets | $-8,000 | $9,000 | $-853,000 | $38,000 |
| Change In Inventory | $126,000 | $-380,000 | $-10,000 | $-194,000 |
| Change In Receivables | $765,000 | $-572,000 | $-205,000 | $47,000 |
| Changes In Account Receivables | $4,000 | $32,000 | $-29,000 | $47,000 |
| Other Non Cash Items | $2,760,000 | $1,976,000 | $14,047,000 | $7,209,000 |
| Stock Based Compensation | $745,000 | $562,000 | $1,575,000 | $0 |
| Provisionand Write Offof Assets | $36,000 | $76,000 | $-99,000 | $-41,000 |
| Depreciation Amortization Depletion | $302,000 | $173,000 | $133,000 | $75,000 |
| Depreciation And Amortization | $302,000 | $173,000 | $133,000 | $75,000 |
| Depreciation | $302,000 | $173,000 | $133,000 | $75,000 |
| Gain Loss On Investment Securities | $-127,000 | $697,000 | $-1,842,000 | $35,000 |
| Net Income From Continuing Operations | $-23,756,000 | $-20,795,000 | $-29,922,000 | $-15,923,000 |
| Income Tax Paid Supplemental Data | - | $0 | $0 | $0 |
| Gain Loss On Sale Of PPE | - | - | - | $0 |
Fetched: 2026-06-20